Skip to content

Michael Baran

Director at Graviton Bioscience.

Earliest Form D on file: Nov 2026

Filed Nov 13, 2026

Graviton Bioscience

ROCK2 inhibitors for fibrotic and autoimmune diseases

Biotech, New York NY

Named, Director.

$5M

sold of $75M offered

Form D

Network

At Graviton Bioscience

6 people